Current Hypothesis:

The differential expression of a set of genes is indicative of distinct cellular functions and states within a heterogeneous cell population. Specifically, we hypothesize that cell populations can be categorized based on their expression profiles of the eight differentially expressed genes across defined clusters, suggesting functional specialization among these cells.

Refined Hypothesis:

The expression profiles of the top differentially expressed genes indicate distinct functional subsets of immune and myeloid cells within the population. Cluster 0 is primarily characterized by genes associated with T cell activation (CD3D), indicating a T cell-rich environment. Cluster 1 shows elevated expression of HLA and CD74 genes, suggesting an antigen-presenting cell (APC) configuration, potentially involving B cells or macrophages. Cluster 2, with markers such as AIF1 and FCER1G, implies a myeloid lineage with potential roles in immune response and inflammation. Cluster 3 and Cluster 4 share common markers (NKG7, B2M), hinting at cytotoxic lymphocyte populations, while Cluster 5 is likely associated with pro-inflammatory monocytes due to elevated LYZ and S100A9. Finally, Cluster 6 further corroborates the presence of APCs with its overlapping HLA genes. Cluster 7, by expressing GPX1 and PF4, may reflect platelet activation or response to oxidative stress. We propose that these gene signatures can be used to accurately differentiate between specific immune cell subtypes, enhancing our understanding of the immune landscape in this biological context.
1. List of cell types with their markers:

[Naive T Cell]: CD3D; CD4; CD8A  
[Activated T Cell]: CD3D; CD69; IL2RA  
[Regulatory T Cell]: FOXP3; CD4; CD25  
[Memory T Cell]: CD45RO; CD3D; LEF1  
[B Cell]: CD19; CD20; CD74  
[T follicular helper Cell]: CXCR5; PDCD1; ICOS  
[Monocyte]: CD14; S100A9; LYZ  
[Pro-inflammatory Monocyte]: CD14; S100A9; CCR2  
[Macrophage]: CD68; AIF1; HLA-DR  
[Dendritic Cell]: CD11C; HLA-DR; CD14  
[Antigen-Presenting Cell]: CD74; HLA-DR; CD80  
[Memory B Cell]: CD27; CD38; IgD  
[Plasma Cell]: IRF4; CD38; XBP1  
[Cytotoxic T Cell]: NKG7; GZMB; CD8A  
[Natural Killer Cell]: NKG7; GZMB; CD56  
[Neutrophil]: CD66b; IL1B; CXCR2  
[Eosinophil]: EPX; IL5; CD125  
[Basal Myeloid Cell]: AIF1; FCER1G; TREM1  
[Platelet]: PF4; GPX1; CD41  
[Epithelial Cell]: KRT18; KRT19; EPCAM  
[Liver Sinusoidal Endothelial Cell]: CD32; CD146; VEC  
[Hepatic Stellate Cell]: DES; FAP; THY1  
[Hepatocyte]: ALB; CYP2E1; APOB  
[Kupffer Cell]: CD68; CD163; TLR4  
[Gamma Delta T Cell]: TCRG; CD3D; NKG2D  
[Regulatory B Cell]: IL10; CD19; PD-L1  

2. Python list of all marker genes:

MARKER_GENES = ['CD3D', 'CD4', 'CD8A', 'CD69', 'IL2RA', 'FOXP3', 'CD25', 'CD45RO', 
                'LEF1', 'CD19', 'CD20', 'CD74', 'CXCR5', 'PDCD1', 'ICOS', 'CD14', 
                'S100A9', 'LYZ', 'AIF1', 'HLA-DR', 'CD11C', 'CD80', 'CD27', 
                'CD38', 'IgD', 'IRF4', 'GZMB', 'NKG7', 'CD56', 'CD66b', 'IL1B', 
                'CXCR2', 'EPX', 'IL5', 'CD125', 'TREM1', 'PF4', 'GPX1', 'CD41', 
                'KRT18', 'KRT19', 'EPCAM', 'CD32', 'CD146', 'VEC', 'DES', 
                'FAP', 'THY1', 'ALB', 'CYP2E1', 'APOB', 'CD163', 'TLR4', 
                'TCRG', 'NKG2D', 'IL10', 'PD-L1']
14.13854193687439 seconds
```json
{
    "1a": {
        "Highly_expressed_genes": {
            "Cluster_0": ["CD3D"],
            "Cluster_1": ["CD74"],
            "Cluster_2": ["AIF1"],
            "Cluster_3": ["NKG7", "GZMB"],
            "Cluster_4": ["NKG7", "CD3D"],
            "Cluster_5": ["AIF1", "S100A9", "CD14", "LYZ"],
            "Cluster_6": ["IL1B", "CD74", "LYZ"],
            "Cluster_7": ["PF4", "GPX1"]
        }
    },
    "1b": {
        "Differential_expression": {
            "Cluster_pairs": {
                "0 vs 1": ["CD74"],
                "0 vs 2": ["AIF1"],
                "0 vs 3": ["NKG7", "GZMB"],
                "0 vs 4": ["NKG7"],
                "0 vs 6": ["CD74", "LYZ"],
                "1 vs 2": ["AIF1", "LYZ"],
                "1 vs 6": ["LYZ"],
                "3 vs 4": ["GZMB"],
                "5 vs 6": ["S100A9"]
            }
        }
    },
    "1c": {
        "Non_informative_genes": []
    },
    "2a": {
        "Lacking_marker_genes_clusters": []
    },
    "3a": {
        "Distinct_cell_types_identified": true
    },
    "3b": {
        "Cell_type_annotations": {
            "Cluster_0": "Naive T Cell",
            "Cluster_1": "Antigen-Presenting Cell",
            "Cluster_2": "Macrophage",
            "Cluster_3": "Cytotoxic T Cell",
            "Cluster_4": "Activated T Cell",
            "Cluster_5": "Pro-inflammatory Monocyte",
            "Cluster_6": "Dendritic Cell",
            "Cluster_7": "Platelet"
        }
    },
    "3c": {
        "Recommended_additional_cell_types": [
            "Regulatory T Cell",
            "Memory T Cell",
            "Neutrophil",
            "Natural Killer Cell",
            "Memory B Cell",
            "Plasma Cell",
            "Gamma Delta T Cell"
        ]
    },
    "3d": {
        "Cluster_for_subgrouping": 5
    },
    "4a": {
        "Confidence_levels": {
            "Cluster_0": "(0.85)",
            "Cluster_1": "(0.75)",
            "Cluster_2": "(0.70)",
            "Cluster_3": "(0.80)",
            "Cluster_4": "(0.65)",
            "Cluster_5": "(0.90)",
            "Cluster_6": "(0.70)",
            "Cluster_7": "(0.60)"
        }
    },
    "4b": {
        "Stable_annotations": {
            "Cluster_0": "Naive T Cell",
            "Cluster_5": "Pro-inflammatory Monocyte" 
        }
    }
}
```
### Refined Hypothesis:

In a cell population characterized by distinct functional states, differential expression of key genes is indicative of specific immune and metabolic responses. 

1. **T Cell Activation**: Cluster 0 (martial genes such as CD3D) is primarily involved in T cell activation and proliferation, suggesting that this cluster may represent activated or proliferative T cells responding to an antigenic stimulus.

2. **B Cell Activation**: Clusters 1 and 6, marked by high expression of HLA-class II molecules (CD74, HLA-DRA, HLA-DRB1) and B cell receptor components (CD79A), suggest the engagement of antigen presentation and B cell activation pathways, indicative of a population of activated B cells or professional antigen-presenting cells (APCs).

3. **Macrophage and Monocyte Response**: Clusters 2 and 5 exhibit increased expression of immune-related genes (AIF1, LST1, and TYROBP) and acute phase proteins (LYZ, FTL), suggesting active monocyte/macrophage populations that likely play a role in inflammatory responses, phagocytosis, and tissue homeostasis.

4. **Natural Killer (NK) Cell Activity**: Cluster 3 shows significant upregulation of genes such as NKG7 and GZMB, characteristic of cytotoxic NK cells, indicating this cluster represents activated NK cells responding to potential pathogen or tumor cells.

5. **Inflammatory Response**: The presence of genes such as CCL5 and IL32 in Cluster 4 could imply a role in attracting other immune cells to inflamed tissues, signaling the activation of inflammatory pathways.

6. **Platelet Activity**: Cluster 7 features genes like PF4 and PPBP, suggesting this cluster is related to platelet activation and the regulation of hemostasis, possibly reflecting responses to injury or inflammation.

Overall, the hypothesis posits that these clusters represent distinct immune cell types or states that respond to specific stimuli, suggesting a coordinated immune response characterized by cellular cross-talk and adaptive regulation of immune functions. Further studies should investigate the functional roles of these differentially expressed genes to elucidate their contribution to immune dynamics in the context of the experimental conditions.
1. List of cell types with their markers:
   
   [Activated T Cell]: CD3D; CD4; CD8A  
   
   [B Cell]: CD79A; CD19; HLA-DRA  
   
   [Professional Antigen-Presenting Cell (APC)]: CD74; HLA-DRB1; CD80  
   
   [Monocyte]: CD14; CCR2; CD68  
   
   [Activated Macrophage]: CD68; AIF1; IL1B  
   
   [Natural Killer (NK) Cell]: NKG7; GZMB; PRF1  
   
   [Inflammatory Macrophage]: CCL5; TNF; IL6  
   
   [Platelet]: PF4; PPBP; GP1BA  
   
   [Dendritic Cell]: CD11C; HLA-DR; CD83  
   
   [Neutrophil]: MPO; S100A8; S100A9  
   
   [Regulatory T Cell (Treg)]: FOXP3; CD25; CTLA4  
   
   [CD8+ Cytotoxic T Cell]: GZMB; PERFORIN; CD8A  
   
   [Mast Cell]: TPSB2; KIT; IL4  
   
   [Memory B Cell]: CD27; CD38; AICDA  
   
   [NKT Cell]: CD56; CD3E; PLZF  

   [Th1 Helper T Cell]: T-BET; IFNG; CD4  
   
   [Th2 Helper T Cell]: GATA3; IL4; CD4  
   
   [Fibroblast]: FAP; COL1A1; ACTA2  
   
   [Endothelial Cell]: CD31; VWF; PECAM1  
   
   [Hepatocyte]: ALB; AFP; CYP3A4  
   
   [Eosinophil]: IL5; CCR3; EDN  
   
   [Monocyte-Derived Dendritic Cell]: IL6; CD11C; CXCL10  

2. Python list of all marker genes:

MARKER_GENES = ['CD3D', 'CD4', 'CD8A', 'CD79A', 'CD19', 'HLA-DRA', 
                'CD74', 'HLA-DRB1', 'CD80', 'CD14', 'CCR2', 'CD68', 
                'AIF1', 'IL1B', 'NKG7', 'GZMB', 'PRF1', 'CCL5', 
                'TNF', 'IL6', 'PF4', 'PPBP', 'GP1BA', 'CD11C', 
                'HLA-DR', 'CD83', 'MPO', 'S100A8', 'S100A9', 
                'FOXP3', 'CD25', 'CTLA4', 'PERFORIN', 'TPSB2', 
                'KIT', 'IL4', 'CD27', 'CD38', 'AICDA', 'CD56', 
                'CD3E', 'PLZF', 'T-BET', 'IFNG', 'GATA3', 'COL1A1', 
                'ACTA2', 'CD31', 'VWF', 'PECAM1', 'ALB', 'AFP', 
                'CYP3A4', 'IL5', 'CCR3', 'EDN', 'CXCL10']
15.930078983306885 seconds
```json
{
  "1a": {
    "highly_expressed_genes": {
      "0": ["CD3E", "CD3D"],
      "1": ["CD74", "HLA-DRA", "CD79A", "HLA-DRB1"],
      "2": ["CD68", "AIF1", "HLA-DRB1"],
      "3": ["CCL5", "PRF1", "NKG7", "GZMB"],
      "4": ["CD3E", "CCL5", "CD3D", "NKG7"],
      "5": ["CD68", "S100A9", "AIF1", "CD14", "S100A8"],
      "6": ["CD74", "HLA-DRA", "IL1B", "HLA-DRB1"],
      "7": ["CCL5", "PF4", "PPBP", "GP1BA"]
    }
  },
  "1b": {
    "differential_expression": {
      "important_genes": ["CCL5", "NKG7", "CD79A", "S100A8", "GZMB", "S100A9"],
      "pairs": {
        "0 vs 4": ["CCL5", "NKG7"],
        "1 vs 2": ["AIF1", "CD79A"],
        "1 vs 6": ["CD79A"],
        "2 vs 5": ["S100A8"],
        "3 vs 4": ["GZMB"],
        "5 vs 6": ["S100A9", "S100A8"]
      }
    }
  },
  "1c": {
    "non_informative_genes": []
  },
  "2a": {
    "clusters_without_marker_genes": []
  },
  "3a": {
    "distinct_clusters": {
      "0": "Activated T Cell",
      "1": "Professional Antigen-Presenting Cell",
      "2": "Activated Macrophage",
      "3": "Natural Killer Cell",
      "4": "CD8+ Cytotoxic T Cell",
      "5": "Inflammatory Macrophage",
      "6": "Professional Antigen-Presenting Cell",
      "7": "Platelet"
    }
  },
  "3b": {
    "cluster_annotations": {
      "0": "Activated T Cell",
      "1": "Professional Antigen-Presenting Cell",
      "2": "Activated Macrophage",
      "3": "Natural Killer Cell",
      "4": "CD8+ Cytotoxic T Cell",
      "5": "Inflammatory Macrophage",
      "6": "Professional Antigen-Presenting Cell",
      "7": "Platelet"
    }
  },
  "3c": {
    "additional_cell_types": ["Memory B Cell", "Regulatory T Cell", "Dendritic Cell"]
  },
  "3d": {
    "recommended_subgrouping": ["Cluster 1", "Cluster 6"]
  },
  "4a": {
    "confidence_levels": {
      "cluster_annotations": {
        "0": 0.85,
        "1": 0.88,
        "2": 0.81,
        "3": 0.83,
        "4": 0.87,
        "5": 0.82,
        "6": 0.80,
        "7": 0.78
      }
    }
  },
  "4b": {
    "stabilized_annotations": ["0", "1", "4"]
  }
}
```
